Relaxins

Industry

CPC
C07K14/64

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/64Relaxins

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Fusion proteins for the treatment of cardiometabolic diseases
- Patent number 12,145,975
- Issue date Nov 19, 2024
- Shattuck Labs, Inc.
- Taylor Schreiber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding relaxin
- Patent number 12,103,955
- Issue date Oct 1, 2024
- ModernaTX, Inc.
- Barry Ticho
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of fibrosis, cardiovascular disease and heart failure wit...
- Patent number 12,097,242
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating kidney failure, and/or improving or stablizing...
- Patent number 12,097,241
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Relaxin fusion polypeptides and uses thereof
- Patent number 11,845,782
- Issue date Dec 19, 2023
- MedImmune Limited
- Weidong Hao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric Relaxin fusions polypeptides
- Patent number 11,795,205
- Issue date Oct 24, 2023
- MedImmune Limited
- Isabelle Sermadiras
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified relaxin polypeptides and their uses
- Patent number 11,786,578
- Issue date Oct 17, 2023
- Ambrx, Inc.
- Vadim Kraynov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified lipidated relaxin B chain peptides and their therapeutic use
- Patent number 11,725,036
- Issue date Aug 15, 2023
- Sanofi
- Olivier Duclos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide dual agonists of GIPR and GLP2R
- Patent number 11,725,037
- Issue date Aug 15, 2023
- University of Copenhagen
- Bolette Hartmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coiled coil immunoglobulin fusion proteins and compositions thereof
- Patent number 11,673,959
- Issue date Jun 13, 2023
- The Scripps Research Institute
- Feng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GIP derivatives and uses thereof
- Patent number 11,633,459
- Issue date Apr 25, 2023
- Novo Nordisk A/S
- Wouter Frederik Johan Hogendorf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding modified relaxin polypeptides
- Patent number 11,439,710
- Issue date Sep 13, 2022
- Ambrx, Inc.
- Vadim Kraynov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified relaxin polypeptides comprising a pharmacokinetic enhancer...
- Patent number 11,364,281
- Issue date Jun 21, 2022
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating heart failure and fibrotic disorders using modi...
- Patent number 11,311,605
- Issue date Apr 26, 2022
- Ambrx, Inc.
- Vadim Kraynov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified relaxin polypeptides comprising a pharmacokinetic enhancer...
- Patent number 11,224,634
- Issue date Jan 18, 2022
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Additive systems for use in protein PEGylation
- Patent number 11,213,589
- Issue date Jan 4, 2022
- Bristol-Myers Squibb Company
- Matthew R. Hickey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein and protein conjugate for diabetes treatment, and applicati...
- Patent number 11,208,451
- Issue date Dec 28, 2021
- ADDA Biotech Inc.
- Shulin Qin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Relaxin fusion polypeptides and uses thereof
- Patent number 11,192,931
- Issue date Dec 7, 2021
- Medlmmune, LLC
- Weidong Hao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cardiovascular disease and heart failure with mo...
- Patent number 11,185,570
- Issue date Nov 30, 2021
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Relaxin immunoglobulin fusion proteins and methods of use
- Patent number 11,161,891
- Issue date Nov 2, 2021
- The Scripps Research Institute
- Feng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GIP-GLP-1 dual agonist compounds and methods
- Patent number 11,008,375
- Issue date May 18, 2021
- Zealand Pharma A/S
- Anne Pernille Tofteng Shelton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified relaxin B chain peptides and their therapeutic use
- Patent number 10,988,524
- Issue date Apr 27, 2021
- Sanofi
- Stéphane Illiano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified lipidated Relaxin B chain peptides and their therapeutic use
- Patent number 10,988,523
- Issue date Apr 27, 2021
- Sanofi
- Denis Brasseur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified lipidated Relaxin B chain peptides and their therapeutic use
- Patent number 10,961,295
- Issue date Mar 30, 2021
- Sanofi
- Olivier Duclos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions related to functional polypeptides embedde...
- Patent number 10,941,188
- Issue date Mar 9, 2021
- The Scripps Research Institute
- Yingjie Peng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for increasing cardiac inflow by administering a compound th...
- Patent number 10,799,561
- Issue date Oct 13, 2020
- Relaxera Pharmazeutische Gesellschaft mbH & Co. KG
- Thomas B. Dschietzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide dual agonists of GIPR and GLP2R
- Patent number 10,774,127
- Issue date Sep 15, 2020
- University of Copenhagen
- Bolette Hartmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment using modified relaxin polypeptides comprising...
- Patent number 10,751,391
- Issue date Aug 25, 2020
- Ambrx, Inc.
- Vadim Kraynov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding relaxin
- Patent number 10,730,924
- Issue date Aug 4, 2020
- ModernaTX, Inc.
- Barry Ticho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified relaxin polypeptides comprising a non-naturally encoded am...
- Patent number 10,702,588
- Issue date Jul 7, 2020
- Ambrx, Inc.
- Vadim Kraynov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME
- Publication number 20240409601
- Publication date Dec 12, 2024
- Tectonic Therapeutic, Inc.
- John Diener
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF RELAXIN AND VASOPRESSIN ANALOGUES FOR TREATMENT OF R...
- Publication number 20240400638
- Publication date Dec 5, 2024
- River 2 Renal Corp.
- Guido Magni
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
- Publication number 20240391975
- Publication date Nov 28, 2024
- Eli Lilly and Company
- Stephanie Ruth COFFIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
- Publication number 20240368240
- Publication date Nov 7, 2024
- Eli Lilly and Company
- Stephanie Ruth COFFIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
- Publication number 20240277813
- Publication date Aug 22, 2024
- Antag Therapeutics ApS
- Alexander HOVARD SPARRE-ULRICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
- Publication number 20240262881
- Publication date Aug 8, 2024
- Shattuck Labs, Inc.
- Taylor SCHREIBER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GIP RECEPTOR AGONIST AND USE THEREOF
- Publication number 20240239863
- Publication date Jul 18, 2024
- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.
- Honghao LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED LIPIDATED RELAXIN B CHAIN PEPTIDES AND THEIR THERAPEUTIC USE
- Publication number 20240218042
- Publication date Jul 4, 2024
- SANOFI
- Olivier DUCLOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modified Relaxin Polypeptides and Their Uses
- Publication number 20240189392
- Publication date Jun 13, 2024
- Ambrx, Inc.
- Vadim KRAYNOV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GIP DERIVATIVES AND USES THEREOF
- Publication number 20240190938
- Publication date Jun 13, 2024
- Novo Nordisk A/S
- Wouter Frederik Johan Hogendorf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFA...
- Publication number 20240059753
- Publication date Feb 22, 2024
- Pep2Tango Therapeutics Inc.
- Cristina Martha RONDINONE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC RELAXIN FUSIONS AND USES THEREOF
- Publication number 20240025958
- Publication date Jan 25, 2024
- MEDIMMUNE LIMITED
- ISABELLE SERMADIRAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION PROTEIN FOR TREATING METABOLIC DISEASES, AND PREPARATION MET...
- Publication number 20240002461
- Publication date Jan 4, 2024
- JIANGNAN UNIVERSITY
- Shenglong ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized GIP Peptide Analogues
- Publication number 20230416330
- Publication date Dec 28, 2023
- Antag Therapeutics ApS
- Mette Marie ROSENKILDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS
- Publication number 20230391845
- Publication date Dec 7, 2023
- Novo Nordisk A/S
- Patrick James Knerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
- Publication number 20230365695
- Publication date Nov 16, 2023
- The Scripps Research Institute
- Feng WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME
- Publication number 20230340058
- Publication date Oct 26, 2023
- Tectonic Therapeutic, Inc.
- John DIENER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GIP/GLP1 CO-AGONIST COMPOUNDS
- Publication number 20230265151
- Publication date Aug 24, 2023
- Eli Lilly and Company
- Jorge ALSINA-FERNANDEZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAIN...
- Publication number 20230201321
- Publication date Jun 29, 2023
- Immatics Biotechnologies GmbH
- Toni WEINSCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED RELAXINS AND METHODS OF USE THEREOF
- Publication number 20230174610
- Publication date Jun 8, 2023
- President and Fellows of Harvard College
- Andrew Kruse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified Relaxin Polypeptides and Their Uses
- Publication number 20230028168
- Publication date Jan 26, 2023
- Ambrx, Inc.
- Vadim KRAYNOV
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20220331402
- Publication date Oct 20, 2022
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified GIP Peptide Analogues
- Publication number 20220298218
- Publication date Sep 22, 2022
- Antag Therapeutics ApS
- Alexander Hovard SPARRE-ULRICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RELAXIN ANALOGS AND METHODS OF USING THE SAME
- Publication number 20220275042
- Publication date Sep 1, 2022
- Eli Lilly and Company
- Petra Verdino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified Relaxin Polypeptides and Their Uses
- Publication number 20220257720
- Publication date Aug 18, 2022
- Ambrx, Inc.
- Vadim KRAYNOV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20220211812
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION
- Publication number 20220160883
- Publication date May 26, 2022
- Bristol-Myers Squibb Company
- Matthew R. Hickey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
- Publication number 20220135639
- Publication date May 5, 2022
- Eli Lilly and Company
- Stephanie Ruth COFFIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RELAXIN FUSION POLYPEPTIDES AND USES THEREOF
- Publication number 20220073584
- Publication date Mar 10, 2022
- Medimmune, LLC
- Weidong HAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE
- Publication number 20220048969
- Publication date Feb 17, 2022
- The Scripps Research Institute
- Feng WANG
- C07 - ORGANIC CHEMISTRY

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Fusion proteins for the treatment of cardiometabolic diseases

Polynucleotides encoding relaxin

Treatment of fibrosis, cardiovascular disease and heart failure wit...

Methods of treating kidney failure, and/or improving or stablizing...

Relaxin fusion polypeptides and uses thereof

Heterodimeric Relaxin fusions polypeptides

Modified relaxin polypeptides and their uses

Modified lipidated relaxin B chain peptides and their therapeutic use

Peptide dual agonists of GIPR and GLP2R

Coiled coil immunoglobulin fusion proteins and compositions thereof

GIP derivatives and uses thereof

Nucleic acids encoding modified relaxin polypeptides

Modified relaxin polypeptides comprising a pharmacokinetic enhancer...

Methods of treating heart failure and fibrotic disorders using modi...

Modified relaxin polypeptides comprising a pharmacokinetic enhancer...

Additive systems for use in protein PEGylation

Protein and protein conjugate for diabetes treatment, and applicati...

Relaxin fusion polypeptides and uses thereof

Method of treating cardiovascular disease and heart failure with mo...

Relaxin immunoglobulin fusion proteins and methods of use

GIP-GLP-1 dual agonist compounds and methods

Modified relaxin B chain peptides and their therapeutic use

Modified lipidated Relaxin B chain peptides and their therapeutic use

Modified lipidated Relaxin B chain peptides and their therapeutic use

Methods and compositions related to functional polypeptides embedde...

Method for increasing cardiac inflow by administering a compound th...

Peptide dual agonists of GIPR and GLP2R

Methods of treatment using modified relaxin polypeptides comprising...

Polynucleotides encoding relaxin

Modified relaxin polypeptides comprising a non-naturally encoded am...

Patents Applicationslast 30 patents

RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME

COMBINATION OF RELAXIN AND VASOPRESSIN ANALOGUES FOR TREATMENT OF R...

PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST

PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST

TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS

FUSION PROTEINS FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES

GIP RECEPTOR AGONIST AND USE THEREOF

MODIFIED LIPIDATED RELAXIN B CHAIN PEPTIDES AND THEIR THERAPEUTIC USE

Modified Relaxin Polypeptides and Their Uses

GIP DERIVATIVES AND USES THEREOF

COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFA...

HETERODIMERIC RELAXIN FUSIONS AND USES THEREOF

FUSION PROTEIN FOR TREATING METABOLIC DISEASES, AND PREPARATION MET...

Optimized GIP Peptide Analogues

GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

RELAXIN-2 FUSION PROTEIN ANALOGS AND METHODS OF USING SAME

GIP/GLP1 CO-AGONIST COMPOUNDS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAIN...

ENGINEERED RELAXINS AND METHODS OF USE THEREOF

Modified Relaxin Polypeptides and Their Uses

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

Modified GIP Peptide Analogues

RELAXIN ANALOGS AND METHODS OF USING THE SAME

Modified Relaxin Polypeptides and Their Uses

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION

PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST

RELAXIN FUSION POLYPEPTIDES AND USES THEREOF

RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE